Epigenetic Target Profiler: A Web Server to Predict Epigenetic Targets of Small Molecules

07 January 2021, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Motivation: The identification of protein targets of small molecules is essential for drug discovery. With the increasing amount of chemogenomic data in the public domain, multiple ligand-based models for target prediction have emerged. However, these models are generally biased by the number of known ligands for different targets, which involves an underrepresentation of epigenetic targets. Epigenetic drug discovery is of increasing importance but there are no open tools for epigenetic target prediction.

Results: We introduce Epigenetic Target Profiler (ETP), a freely accessible and easy-to-use web application for the prediction of epigenetic targets of small molecules. For a query compound, ETP predicts its bioactivity profile over a panel of 55 different epigenetic targets. To that aim, ETP uses a consensus model based on two binary classification models for each target, relying on support vector machines and built on molecular fingerprints of different design. A distance-to-model parameter related to the reliability of the predictions is included to facilitate their interpretability and assist the identification of small molecules with potential epigenetic activity.

Keywords

Chemoinformatics
Chemogenomics
Drug Discovery
Epigenetics
Epi-informatics
Machine Learning
Structure-Activity Relationships
webservice
OpenScience

Supplementary materials

Title
Description
Actions
Title
Epigenetic Target Profiler SuppInfo
Description
Actions

Supplementary weblinks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.